UF Innovate | Accelerate @ Sid Martin Biotech

Ascend Acquires Beacon Gene Therapy Manufacturing Site

Ascend Advanced Therapies, a gene therapy development partner, has purchased Beacon Therapeutics’ contract, manufacturing, and controls team—along with the company's site, previously owned by UF Innovate | Accelerate graduate AGTC, located in Alachua, FL—a town considered to be a “biotech hub” in the state. The acquisition introduces a good manufacturing practice (GMP) plant into the fold, along with process and analytical development capabilities.

Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics

BARDA is awarding over $240 million to support Project NextGen clinical studies for COVID-19 vaccines, including investments in cold-chain sample management, genomic sequencing, and increased central laboratory capacity for sample testing. UF Innovate | Accelerate client BioInfoExperts is among the recipients. BARDA provided $4 million to the startup to provide genomic sequencing of COVID-19.

Oragenics, Inc. Announces Private Placement

Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.

Hack #10 | Adaptive Pivots Can Help You Stay Ahead of the Curve

In today’s ever-changing business landscape, the ability to adapt and make strategic pivots is essential for long-term success. Businesses often face challenges such as dry spells, economic uncertainties, and market corrections that necessitate a shift in strategies and operations. Let’s explore three key areas where businesses can pivot to navigate obstacles and growth effectively to stay ahead of the curve.

Pheronym Lands $1 Million National Science Foundation Sbir Phase II Grant

UF Innovate | Accelerate alum, Pheronym, an ag-biotech pest management company, has been awarded a second non-dilutive National Science Foundation (NSF) SBIR Phase II for $1 Million. The grant will fund the final steps to scaling commercial manufacturing of their sustainable, eco-, and climate-friendly approach to pest control. The target pests include Thrips, a globally important pest that developed resistance to chemical pesticides.

Dmitry Rinberg on the Mysteries of Smell

"Don't miss this fascinating interview with Dmitry Rinberg, Co-founder and Chief Science Advisor of Canaery, a resident of UF Innovate | Accelerate, as he explores the mysteries of smell with Vasant Dhar. Join AI-pioneer Vasant Dhar as he hosts 'Brave New World' and discover the transformation of humanity by machines in the post-COVID era. The conversation will touch on various topics such as work, health, faith, emotional well-being, government, democracy, and freedom."
1 2 3 37